See more : HORNG TERNG (7751.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Xilong Scientific Co., Ltd. (002584.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Xilong Scientific Co., Ltd., a leading company in the Chemicals industry within the Basic Materials sector.
- 1895 Bancorp of Wisconsin, Inc. (BCOW) Income Statement Analysis – Financial Results
- Renergen Limited (RLT.AX) Income Statement Analysis – Financial Results
- Stellar Capital Services Limited (STELLAR.BO) Income Statement Analysis – Financial Results
- Chanjet Information Technology Company Limited (1588.HK) Income Statement Analysis – Financial Results
- Genuine Parts Company (GPC) Income Statement Analysis – Financial Results
Xilong Scientific Co., Ltd. (002584.SZ)
About Xilong Scientific Co., Ltd.
Xilong Scientific Co., Ltd. researches and develops, manufactures, and sells chemical reagents in China. The company offers chemical reagents, PCB reagents, high purity reagents, food additives, active pharmaceutical and chemical materials, and lab glassware products. It also exports its products. The company was formerly known as Xilong Chemical Co., Ltd. and changed its name to Xilong Scientific Co., Ltd. in December 2015. Xilong Scientific Co., Ltd. was founded in 1983 and is based in Shantou, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.69B | 6.18B | 6.84B | 6.24B | 3.34B | 3.36B | 3.39B | 2.93B | 2.51B | 2.20B | 2.24B | 1.54B | 1.28B | 1.16B | 881.98M | 766.71M |
Cost of Revenue | 7.23B | 5.74B | 6.28B | 5.76B | 2.81B | 2.82B | 2.93B | 2.49B | 2.09B | 1.82B | 1.97B | 1.30B | 1.05B | 951.53M | 721.22M | 627.73M |
Gross Profit | 459.70M | 441.50M | 557.42M | 479.45M | 532.08M | 537.47M | 460.74M | 437.88M | 419.08M | 374.40M | 266.70M | 248.81M | 235.95M | 212.63M | 160.76M | 138.98M |
Gross Profit Ratio | 5.98% | 7.14% | 8.15% | 7.68% | 15.94% | 16.02% | 13.57% | 14.95% | 16.67% | 17.03% | 11.91% | 16.11% | 18.42% | 18.26% | 18.23% | 18.13% |
Research & Development | 95.70M | 90.47M | 118.97M | 102.72M | 87.58M | 81.75M | 59.22M | 40.28M | 36.84M | 32.72M | 25.17M | 12.72M | 9.87M | 7.61M | 4.55M | 4.45M |
General & Administrative | 48.61M | 29.45M | 49.76M | 41.32M | 29.30M | 38.35M | 39.47M | 34.58M | 32.67M | 36.59M | 29.69M | 25.08M | 20.08M | 17.91M | 11.79M | 15.74M |
Selling & Marketing | 23.88M | 101.43M | 108.63M | 120.17M | 183.13M | 182.98M | 156.49M | 143.77M | 131.23M | 133.91M | 100.03M | 97.83M | 75.98M | 66.73M | 49.53M | 39.23M |
SG&A | 72.48M | 130.88M | 158.39M | 161.49M | 212.43M | 221.33M | 195.96M | 178.35M | 163.90M | 170.51M | 129.72M | 122.91M | 96.06M | 84.64M | 61.32M | 54.98M |
Other Expenses | 245.51M | 92.03M | 85.84M | 87.62M | 96.54M | -646.28K | -5.14M | 6.52M | 5.46M | 8.62M | 7.33M | 10.08M | 8.45M | 6.25M | 4.95M | 1.47M |
Operating Expenses | 413.69M | 313.38M | 363.20M | 351.82M | 396.55M | 392.61M | 354.75M | 324.09M | 278.95M | 260.52M | 201.44M | 173.96M | 138.51M | 122.37M | 90.36M | 78.67M |
Cost & Expenses | 7.65B | 6.06B | 6.64B | 6.12B | 3.20B | 3.21B | 3.29B | 2.81B | 2.37B | 2.08B | 2.17B | 1.47B | 1.18B | 1.07B | 811.58M | 706.39M |
Interest Income | 5.65M | 9.13M | 7.01M | 12.52M | 3.74M | 4.21M | 3.40M | 7.44M | 3.79M | 2.87M | 7.69M | 10.44M | 4.86M | 1.77M | 1.66M | 0.00 |
Interest Expense | 75.89M | 49.08M | 67.50M | 65.09M | 63.39M | 52.33M | 9.26M | 5.04M | 12.41M | 12.70M | 9.10M | 4.70M | 5.87M | 6.71M | 5.35M | 3.15M |
Depreciation & Amortization | 49.30M | 47.80M | 37.37M | 34.45M | 39.74M | 38.99M | 36.98M | 31.93M | 26.44M | 21.29M | 18.25M | 13.25M | 9.43M | 8.14M | 6.38M | 4.00M |
EBITDA | 153.08M | 219.60M | 322.00M | 187.36M | 149.70M | 160.46M | 150.07M | 146.35M | 149.27M | 133.22M | 85.87M | 97.39M | 113.16M | 96.27M | 77.08M | 60.55M |
EBITDA Ratio | 1.99% | 3.80% | 5.39% | 2.83% | 4.86% | 6.11% | 4.37% | 5.37% | 7.18% | 6.60% | 4.42% | 7.00% | 9.50% | 9.27% | 9.25% | 8.86% |
Operating Income | 46.01M | 190.50M | 334.08M | 146.81M | 125.59M | 69.54M | 104.89M | 105.10M | 116.04M | 91.40M | 52.23M | 67.61M | 89.55M | 84.68M | 62.75M | 53.54M |
Operating Income Ratio | 0.60% | 3.08% | 4.89% | 2.35% | 3.76% | 2.07% | 3.09% | 3.59% | 4.62% | 4.16% | 2.33% | 4.38% | 6.99% | 7.27% | 7.12% | 6.98% |
Total Other Income/Expenses | -3.09M | -1.66M | -2.26M | -64.37M | -79.40M | -646.28K | -5.14M | 5.54M | 4.71M | 8.44M | 6.29M | 10.04M | 8.30M | 4.09M | 4.89M | 1.45M |
Income Before Tax | 42.92M | 102.74M | 227.25M | 81.25M | 46.20M | 68.89M | 99.76M | 110.64M | 120.75M | 99.23M | 58.51M | 77.65M | 97.86M | 88.76M | 67.65M | 54.99M |
Income Before Tax Ratio | 0.56% | 1.66% | 3.32% | 1.30% | 1.38% | 2.05% | 2.94% | 3.78% | 4.80% | 4.51% | 2.61% | 5.03% | 7.64% | 7.62% | 7.67% | 7.17% |
Income Tax Expense | 8.33M | 16.06M | 9.32M | 17.56M | 11.38M | 5.62M | 14.79M | 19.98M | 24.06M | 17.79M | 10.60M | 13.19M | 15.58M | 15.87M | 10.37M | 8.29M |
Net Income | 33.35M | 89.06M | 187.06M | 58.19M | 38.53M | 70.58M | 92.27M | 96.79M | 90.79M | 77.53M | 48.61M | 64.30M | 82.28M | 72.89M | 57.28M | 46.70M |
Net Income Ratio | 0.43% | 1.44% | 2.74% | 0.93% | 1.15% | 2.10% | 2.72% | 3.31% | 3.61% | 3.53% | 2.17% | 4.16% | 6.42% | 6.26% | 6.49% | 6.09% |
EPS | 0.06 | 0.15 | 0.32 | 0.10 | 0.07 | 0.12 | 0.16 | 0.17 | 0.16 | 0.16 | 0.10 | 0.13 | 0.18 | 0.20 | 0.15 | 0.15 |
EPS Diluted | 0.06 | 0.15 | 0.32 | 0.10 | 0.07 | 0.12 | 0.16 | 0.17 | 0.16 | 0.16 | 0.10 | 0.13 | 0.18 | 0.20 | 0.15 | 0.15 |
Weighted Avg Shares Out | 555.80M | 585.22M | 585.22M | 585.22M | 585.22M | 585.22M | 576.66M | 569.35M | 567.46M | 496.98M | 506.33M | 502.36M | 447.17M | 371.91M | 376.83M | 307.26M |
Weighted Avg Shares Out (Dil) | 555.80M | 585.22M | 585.22M | 585.22M | 585.22M | 588.15M | 576.66M | 569.35M | 567.46M | 496.98M | 506.33M | 502.36M | 447.17M | 371.91M | 376.83M | 307.26M |
Source: https://incomestatements.info
Category: Stock Reports